Literature DB >> 28736755

Risky Decision Making in Neurofibromatosis Type 1: An Exploratory Study.

Rachel K Jonas1, EunJi Roh1, Caroline A Montojo1, Laura A Pacheco1, Tena Rosser2, Alcino J Silva3, Carrie E Bearden1.   

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is a monogenic disorder affecting cognitive function. About one third of children with NF1 have attentional disorders, and the cognitive phenotype is characterized by impairment in prefrontally-mediated functions. Mouse models of NF1 show irregularities in GABA release and striatal dopamine metabolism. We hypothesized that youth with NF1 would show abnormal behavior and neural activity on a task of risk-taking reliant on prefrontal-striatal circuits.
METHODS: Youth with NF1 (N=29) and demographically comparable healthy controls (N=22), ages 8-19, were administered a developmentally sensitive gambling task, in which they chose between low-risk gambles with a high probability of obtaining a small reward, and high-risk gambles with a low probability of obtaining a large reward. We used functional magnetic resonance imaging (fMRI) to investigate neural activity associated with risky decision making, as well as age-associated changes in these behavioral and neural processes.
RESULTS: Behaviorally, youth with NF1 tended to make fewer risky decisions than controls. Neuroimaging analyses revealed significantly reduced neural activity across multiple brain regions involved in higher-order semantic processing and motivation (i.e., anterior cingulate, paracingulate, supramarginal, and angular gyri) in patients with NF1 relative to controls during the task. We also observed atypical age-associated changes in neural activity in patients with NF1, such that during risk taking, neural activity tended to decrease with age in controls, whereas it tended to increase with age in patients with NF1.
CONCLUSIONS: Findings suggest that developmental trajectories of neural activity during risky decision-making may be disrupted in youth with NF1.

Entities:  

Keywords:  Decision-Making; Development; Functional MRI; Neurofibromatosis Type I; Phenotype-Genotype; Psychiatric Disorders

Year:  2017        PMID: 28736755      PMCID: PMC5518467          DOI: 10.1016/j.bpsc.2016.12.003

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN: 2451-9022


  44 in total

Review 1.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

2.  Modeling group fMRI data.

Authors:  Jeanette A Mumford; Russell A Poldrack
Journal:  Soc Cogn Affect Neurosci       Date:  2007-09       Impact factor: 3.436

3.  Dorsal anterior cingulate cortex: a role in reward-based decision making.

Authors:  George Bush; Brent A Vogt; Jennifer Holmes; Anders M Dale; Douglas Greve; Michael A Jenike; Bruce R Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 4.  The reward circuit: linking primate anatomy and human imaging.

Authors:  Suzanne N Haber; Brian Knutson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

5.  Neurofibromin regulates corticostriatal inhibitory networks during working memory performance.

Authors:  Carrie Shilyansky; Katherine H Karlsgodt; Damian M Cummings; Kyriaki Sidiropoulou; Molly Hardt; Alex S James; Dan Ehninger; Carrie E Bearden; Panayiota Poirazi; J David Jentsch; Tyrone D Cannon; Michael S Levine; Alcino J Silva
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

6.  Treatment of ADHD in neurofibromatosis type 1.

Authors:  Victor-F Mautner; Lan Kluwe; Sarang D Thakker; Robert A Leark
Journal:  Dev Med Child Neurol       Date:  2002-03       Impact factor: 5.449

Review 7.  Motivating forces of human actions. Neuroimaging reward and social interaction.

Authors:  Henrik Walter; Birgit Abler; Angela Ciaramidaro; Susanne Erk
Journal:  Brain Res Bull       Date:  2005-07-25       Impact factor: 4.077

8.  Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.

Authors:  Jacquelyn A Brown; Ryan J Emnett; Crystal R White; Carla M Yuede; Sara B Conyers; Karen L O'Malley; David F Wozniak; David H Gutmann
Journal:  Hum Mol Genet       Date:  2010-09-07       Impact factor: 6.150

9.  Neural integration of risk and effort costs by the frontal pole: only upon request.

Authors:  Christopher J Burke; Christian Brünger; Thorsten Kahnt; Soyoung Q Park; Philippe N Tobler
Journal:  J Neurosci       Date:  2013-01-23       Impact factor: 6.167

10.  Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1.

Authors:  Steffie N Tomson; Matthew J Schreiner; Manjari Narayan; Tena Rosser; Nicole Enrique; Alcino J Silva; Genevera I Allen; Susan Y Bookheimer; Carrie E Bearden
Journal:  Hum Brain Mapp       Date:  2015-08-25       Impact factor: 5.038

View more
  1 in total

1.  Neurofibromatosis Type 1 with Massive Ventricular Polyposis: First Report in the Medical Literature.

Authors:  Georgi Tchernev; Anastasiya Atanasova Chokoeva; Uwe Wollina; Torello Lotti; Georgi Konstantinov Maximov; Ilia Lozev
Journal:  Open Access Maced J Med Sci       Date:  2018-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.